Cargando…
Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products
BACKGROUND: Successful delivery of cell-based therapeutics into patients is compromised by their short shelf-life upon release from production facilities due to the living nature of the active component that rapidly loses viability, and therefore its properties. In this context, the use of appropria...
Autores principales: | Mirabel, Clémentine, Puente-Massaguer, Eduard, del Mazo-Barbara, Anna, Reyes, Blanca, Morton, Philip, Gòdia, Francesc, Vives, Joaquim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201632/ https://www.ncbi.nlm.nih.gov/pubmed/30355298 http://dx.doi.org/10.1186/s12967-018-1659-4 |
Ejemplares similares
-
Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
por: Grau-Vorster, Marta, et al.
Publicado: (2019) -
Integrating nanoparticle quantification and statistical design of experiments for efficient HIV-1 virus-like particle production in High Five cells
por: Puente-Massaguer, Eduard, et al.
Publicado: (2020) -
HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study
por: Grau-Vorster, Marta, et al.
Publicado: (2019) -
Quality Assessment of Virus-Like Particles at Single Particle Level: A Comparative Study
por: González-Domínguez, Irene, et al.
Publicado: (2020) -
PEI-Mediated Transient Transfection of High Five Cells at Bioreactor Scale for HIV-1 VLP Production
por: Puente-Massaguer, Eduard, et al.
Publicado: (2020)